Zoetis Inc. is a global leader in animal health, dedicated to supporting the health and well-being of animals through innovative products and services. The company's mission is to empower veterinarians and livestock producers with solutions that enhance animal health and productivity. Zoetis focuses on research and development to create a diverse portfolio of vaccines, medicines, and diagnostic tools for both companion animals and livestock. Its strategy emphasizes sustainability, collaboration with stakeholders, and leveraging advanced technologies to meet the evolving needs of the animal health market, ultimately improving the quality of life for animals and the people who care for them.

ZOETIS INC

Zoetis (ZTS) is facing a significant decline in its stock price, dropping over 9% following a disappointing earnings forecast. The company projected its full-year adjusted earnings per share (EPS) to be between $6.00 and $6.10, falling short of the analysts' consensus estimate of $6.28. This underperformance has raised concerns among...

Zoetis Shares Drop Over 5% After Lowered EPS Forecast Falls Short of Analyst Expectations

Zoetis is navigating a turbulent earnings season, with its stock plummeting over 9% after a disappointing EPS forecast that fell short of analyst expectations. Can the company leverage its strong fundamentals and market position to turn this setback into a strategic opportunity for growth?